A detailed history of Franklin Resources Inc transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 26,837 shares of FDMT stock, worth $552,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,837
Previous 52,564 48.94%
Holding current value
$552,305
Previous $1.06 Million 19.64%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$17.03 - $35.87 $438,130 - $922,827
-25,727 Reduced 48.94%
26,837 $855,000
Q4 2023

Feb 09, 2024

BUY
$9.76 - $21.25 $372,851 - $811,792
38,202 Added 265.99%
52,564 $1.06 Million
Q3 2023

Nov 13, 2023

SELL
$12.64 - $19.76 $682 - $1,067
-54 Reduced 0.37%
14,362 $182,000
Q2 2023

Aug 11, 2023

BUY
$15.16 - $23.26 $218,546 - $335,316
14,416 New
14,416 $260,000

Others Institutions Holding FDMT

About 4D Molecular Therapeutics, Inc.


  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $666M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.